Nice (NICE) Increases Yet Falls Behind Market: What Investors Need to Know

Nice (NICE) closed the most recent trading day at $111.86, moving +1.25% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 1.97%. Meanwhile, the Dow experienced a rise of 2.47%, and the technology-dominated Nasdaq saw an increase of 2.18%.

Coming into today, shares of the software company had lost 6.01% in the past month. In that same time, the Computer and Technology sector lost 3.67%, while the S&P 500 lost 1.49%.

Investors will be eagerly watching for the performance of Nice in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on February 19, 2026. In that report, analysts expect Nice to post earnings of $3.23 per share. This would mark year-over-year growth of 6.95%. In the meantime, our current consensus estimate forecasts the revenue to be $778.66 million, indicating a 7.91% growth compared to the corresponding quarter of the prior year.

For the annual period, the Zacks Consensus Estimates anticipate earnings of $12.28 per share and a revenue of $2.94 billion, signifying shifts of +10.43% and +7.4%, respectively, from the last year.

It's also important for investors to be aware of any recent modifications to analyst estimates for Nice. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.21% lower. As of now, Nice holds a Zacks Rank of #4 (Sell).

With respect to valuation, Nice is currently being traded at a Forward P/E ratio of 9.51. This signifies a discount in comparison to the average Forward P/E of 19.86 for its industry.

It's also important to note that NICE currently trades at a PEG ratio of 1.33. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. NICE's industry had an average PEG ratio of 1.12 as of yesterday's close.

The Internet - Software industry is part of the Computer and Technology sector. This industry, currently bearing a Zacks Industry Rank of 93, finds itself in the top 38% echelons of all 250+ industries.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Nice (NICE): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research